StemCells, Inc. Reports First Quarter 2013 Financial Results and Provides Business Update
09 mai 2013 16h05 HE
|
StemCells, Inc.
NEWARK, Calif., May 9, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Announces Webcast to Discuss First Quarter 2013 Financial Results and Business Update
07 mai 2013 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., May 7, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Adds Byers Eye Institute at Stanford as Second Site for Phase I/II Clinical Trial in Dry Age-Related Macular Degeneration
18 avr. 2013 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., April 18, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced the addition of the Byers Eye Institute at Stanford, located in Palo Alto, Calif., as a second site for...
StemCells, Inc. to Participate at 2013 Regen Med Investor Day in New York
15 avr. 2013 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., April 15, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that President and CEO Martin McGlynn will present an update on the Company's programs and operations...
StemCells, Inc. Enters Agreement to Receive $19.3 Million From California Institute for Regenerative Medicine to Help Fund IND for Alzheimer's Disease
11 avr. 2013 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., April 11, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced that it has entered into an agreement with the California Institute for Regenerative Medicine (CIRM)...
CORRECTION -- StemCells, Inc. Closes $10 Million Debt Financing
09 avr. 2013 16h18 HE
|
StemCells, Inc.
NEWARK, Calif., April 9, 2013 (GLOBE NEWSWIRE) -- In a press release issued under the same headline earlier today by StemCells, Inc. (Nasdaq:STEM), please note that in the first paragraph of the...
StemCells, Inc. Closes $10 Million Debt Financing
09 avr. 2013 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., April 9, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced that it has closed a $10 million debt financing from Silicon Valley Bank (SVB). The loan funds will be...
StemCells, Inc. Expands Patent Portfolio
20 mars 2013 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., March 20, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced that it has acquired from NsGene A/S, a privately held Danish biotechnology company, a patent family...
StemCells, Inc. Reports Fourth Quarter and Full Year 2012 Financial Results and Provides Business Update
19 mars 2013 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., March 19, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Announces First Patient Cohort Completes Spinal Cord Injury Trial - Gains in Sensory Function Persist 12 Months After Stem Cell Transplant
12 févr. 2013 07h30 HE
|
StemCells, Inc.
NEWARK, Calif., Feb. 12, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced that the twelve-month data from the first patient cohort in the Company's Phase I/II clinical trial of...